Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Metabolism in vitro and in vivo of the DNA base adduct, M1G.

Authors: Knutson, Charles G; Akingbade, Dapo; Crews, Brenda C; Voehler, Markus; Stec, Donald F; Marnett, Lawrence J

Published In Chem Res Toxicol, (2007 Mar)

Abstract: Oxidative damage is considered a major contributing factor to genetic diseases including cancer. Our laboratory is evaluating endogenously formed DNA adducts as genomic biomarkers of oxidative injury. Recent efforts have focused on investigating the metabolic stability of adducts in vitro and in vivo. Here, we demonstrate that the base adduct, M1G, undergoes oxidative metabolism in vitro in rat liver cytosol (RLC, Km = 105 microM and vmax/Km = 0.005 min-1 mg-1) and in vivo when administered intravenously to male Sprague Dawley rats. LC-MS analysis revealed two metabolites containing successive additions of 16 amu. One- and two-dimensional NMR experiments showed that oxidation occurred first at the 6-position of the pyrimido ring, forming 6-oxo-M1G, and then at the 2-position of the imidazole ring, yielding 2,6-dioxo-M1G. Authentic 6-oxo-M1G was chemically synthesized and observed to undergo metabolism to 2,6-dioxo-M1G in RLC (Km = 210 microM and vmax/Km = 0.005 min-1 mg-1). Allopurinol partially inhibited M1G metabolism (75%) and completely inhibited 6-oxo-M1G metabolism in RLC. These inhibition studies suggest that xanthine oxidase is the principal enzyme acting on M1G in RLC and the only enzyme that converts 6-oxo-M1G to 2,6-dioxo-M1G. Both M1G and 6-oxo-M1G are better substrates (5-fold) for oxidative metabolism in RLC than the deoxynucleoside, M1dG. Alternative repair pathways or biological processing of M1dG makes the fate of M1G of interest as a potential marker of oxidative damage in vivo.

PubMed ID: 17311424 Exiting the NIEHS site

MeSH Terms: Allopurinol/blood; Animals; Biotransformation; Cytosol/metabolism; DNA Adducts/metabolism*; DNA Adducts/pharmacokinetics; DNA Adducts/urine; Indicators and Reagents; Kinetics; Liver/metabolism; Male; Oxidation-Reduction; Purines/metabolism*; Purines/pharmacokinetics; Purines/urine; Pyrimidines/metabolism*; Pyrimidines/pharmacokinetics; Pyrimidines/urine; Rats; Rats, Sprague-Dawley

Back
to Top